Original Query: ALL
Previous Study | Return to List | Next Study

Study of Doxil in the Treatment of Patients With Refractory Idiopathic Thrombocytopenic Purpura

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00107913
Recruitment Status : Unknown
Verified April 2005 by Hematology and Oncology Specialists.
Recruitment status was:  Recruiting
First Posted : April 12, 2005
Last Update Posted : June 24, 2005
Information provided by:
Hematology and Oncology Specialists

No Study Results Posted on for this Study
  Recruitment Status : Unknown
  Primary Completion Date : No date given
  Estimated Study Completion Date : April 2005